Bactiguard Holding AB (publ) (ST:BACTI-B) — Market Cap & Net Worth
Market Cap & Net Worth: Bactiguard Holding AB (publ) (BACTI-B)
Bactiguard Holding AB (publ) (ST:BACTI-B) has a market capitalization of $61.64 Million (Skr572.76 Million) as of May 4, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #21069 globally and #379 in its home market, demonstrating a 5.13% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bactiguard Holding AB (publ)'s stock price Skr18.45 by its total outstanding shares 31043885 (31.04 Million). Analyse BACTI-B cash generation efficiency to see how efficiently the company converts income to cash.
Bactiguard Holding AB (publ) Market Cap History: 2015 to 2026
Bactiguard Holding AB (publ)'s market capitalization history from 2015 to 2026. Data shows growth from $37.42 Million to $61.64 Million (6.61% CAGR).
Bactiguard Holding AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bactiguard Holding AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.31x
Bactiguard Holding AB (publ)'s market cap is 0.31 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $56.46 Million | $118.74 Million | -$26.85 Million | 0.48x | N/A |
| 2017 | $76.84 Million | $147.46 Million | -$3.25 Million | 0.52x | N/A |
| 2018 | $134.30 Million | $150.10 Million | -$14.93 Million | 0.89x | N/A |
| 2019 | $275.95 Million | $184.99 Million | $16.26 Million | 1.49x | 16.98x |
| 2020 | $477.74 Million | $172.31 Million | -$38.39 Million | 2.77x | N/A |
| 2021 | $551.23 Million | $169.49 Million | -$58.77 Million | 3.25x | N/A |
| 2022 | $368.83 Million | $223.56 Million | -$52.88 Million | 1.65x | N/A |
| 2023 | $206.46 Million | $203.99 Million | -$138.38 Million | 1.01x | N/A |
| 2024 | $117.93 Million | $243.68 Million | -$29.82 Million | 0.48x | N/A |
| 2025 | $66.48 Million | $215.92 Million | -$7.84 Million | 0.31x | N/A |
Competitor Companies of BACTI-B by Market Capitalization
Companies near Bactiguard Holding AB (publ) in the global market cap rankings as of May 4, 2026.
Key companies related to Bactiguard Holding AB (publ) by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
Bactiguard Holding AB (publ) Historical Marketcap From 2015 to 2026
Between 2015 and today, Bactiguard Holding AB (publ)'s market cap moved from $37.42 Million to $ 61.64 Million, with a yearly change of 6.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr61.64 Million | -7.29% |
| 2025 | Skr66.48 Million | -43.63% |
| 2024 | Skr117.93 Million | -42.88% |
| 2023 | Skr206.46 Million | -44.02% |
| 2022 | Skr368.83 Million | -33.09% |
| 2021 | Skr551.23 Million | +15.38% |
| 2020 | Skr477.74 Million | +73.12% |
| 2019 | Skr275.95 Million | +105.47% |
| 2018 | Skr134.30 Million | +74.78% |
| 2017 | Skr76.84 Million | +36.09% |
| 2016 | Skr56.46 Million | +50.89% |
| 2015 | Skr37.42 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Bactiguard Holding AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $61.64 Million USD |
| MoneyControl | $61.64 Million USD |
| MarketWatch | $61.64 Million USD |
| marketcap.company | $61.64 Million USD |
| Reuters | $61.64 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bactiguard Holding AB (publ)
Bactiguard Holding AB (publ), a medTech company, provides infection prevention technology and solutions in orthopedics, cardiology, neurology, urology, and vascular access areas. It also operates through license partnerships with global MedTech companies that apply the technology to medical devices and sell them under own brand and co-branded. The company also has a portfolio of wound management … Read more